Multiple sources, shared readouts: the attribution gap in circular RNA immunotherapy for esophageal squamous cell carcinoma
Therapeutic circular RNAs (circRNAs) are progressing from preclinical development to clinical evaluation, and esophageal squamous cell carcinoma (ESCC) may become a future indication for circRNA-based immunotherapy, potentially including first-line use…